View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Allergy/Asthma News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 25, 2024
4 min read
Save

Allergy specialists react to controversial sesame post by In-N-Out president

Allergy specialists react to controversial sesame post by In-N-Out president

Popular fast-food chain In-N-Out Burger announced on June 12 the inclusion of sesame flour in its buns, causing concern for those with an allergy. The company cited supplier issues as the main driver for the change.

SPONSORED CONTENT
June 25, 2024
1 min read
Save

Vtama cream approved for treatment of psoriasis, atopic dermatitis in Japan

Vtama cream approved for treatment of psoriasis, atopic dermatitis in Japan

Vtama cream 1% has been approved in Japan for the treatment of adults with psoriasis as well as patients aged 12 years and older with atopic dermatitis, Dermavant Sciences announced in a press release.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
June 25, 2024
3 min read
Save

Pediatric egg-induced anaphylaxis may present differing symptoms than other food allergies

Pediatric egg-induced anaphylaxis may present differing symptoms than other food allergies

Children experiencing egg-induced anaphylaxis may be seeing certain symptoms that differentiate them from other food-induced anaphylaxis, according to a study published in Annals of Allergy, Asthma and Immunology.

SPONSORED CONTENT
June 24, 2024
3 min read
Save

Biologics therapy may lead to greater asthma remission in non-white patients

Biologics therapy may lead to greater asthma remission in non-white patients

SAN DIEGO — Asthma remission may occur more often with the use of biologics, but non-white patients receive fewer biologics than white patients, according to an abstract presented at the American Thoracic Society International Conference.

SPONSORED CONTENT
June 24, 2024
3 min read
Save

Severe asthma patients facing social disparities see gaps in care

Severe asthma patients facing social disparities see gaps in care

Patients with severe asthma saw less escalation of care after uncontrolled disease, with non-white patients showing significantly less care, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

SPONSORED CONTENT
June 24, 2024
1 min read
Save

Building wealth: Take these initial steps post-training

Building wealth: Take these initial steps post-training

The concept of delayed gratification has been ingrained in us throughout medical school and residency. This mentality can sometimes lead to explosive spending as an attending when one enjoys a significant salary boost.

SPONSORED CONTENT
June 21, 2024
2 min read
Save

New initiative aims to eliminate harmful use of race in clinical algorithms

New initiative aims to eliminate harmful use of race in clinical algorithms

The Council for Medical Specialty Societies, or CMSS, announced the launch of a new initiative that aims to reduce clinicians’ reliance on race in clinical decision-making and patient harms.

SPONSORED CONTENT
June 21, 2024
7 min read
Save

‘Small actions, big impact’: How physicians can identify, respond to microaggressions

‘Small actions, big impact’: How physicians can identify, respond to microaggressions

Microaggressions are just as commonplace in medical settings as other workplaces, and although they may be small behaviors, experts said they can have serious impacts on employee morale and patient care when they go unaddressed.

SPONSORED CONTENT
June 21, 2024
3 min read
Save

Q&A: How to use ‘buy and bill’ for biologic treatment in allergy, asthma care

Q&A: How to use ‘buy and bill’ for biologic treatment in allergy, asthma care

As biologics become more popular for a growing number of indications, practices need to figure out the most cost-effective ways to provide these treatments to their patients.

SPONSORED CONTENT
June 20, 2024
2 min read
Save

Ruxolitinib cream 1.5% exhibits long-term safety in pediatric atopic dermatitis

Ruxolitinib cream 1.5% exhibits long-term safety in pediatric atopic dermatitis

Year-long ruxolitinib cream 1.5% treatment among children aged 2 to 11 years with extensive moderate to severe atopic dermatitis is safe, according to results presented at the Revolutionizing Atopic Dermatitis Conference.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails